Immunisation, vaccine and travel advice for Mauritania.


1. The South (all year round) and the North (from July until October):

There is a high risk of malaria.

Recommended adult regimen:

Mefloquine 250mg weekly. Begin 10 2-3 weeks before travel to affected area and continue for four weeks after leaving. 


Doxycycline 100mg daily. Begin one to two days before travel to affected area and continue for four weeks after leaving.


Atovaquone 250mg plus proguanil 100mg daily (Malarone). Begin one to two days before travel to affected area and continue for seven days after leaving.

Alternative regimen:

Healthcare professionals only may check with the National Travel Health Network and Centre (NaTHNaC) on 0845 6026712 (Mon, Fri, 9.00-11.00am & 1.00-2.00pm; Tue, Wed, Thur, 9.00-11.00am & 1.00-3.30pm; closed on Bank Holidays).

2. Rest of the country:

There is low to no risk of malaria. Advise mosquito bite avoidance.


Travellers should be up to date with routinely recommended vaccinations according to the routine UK immunisation programme.

Vaccination recommended for travellers whose activities put them at increased risk, including those visiting friends and relatives, those in contact with an infected person, young children, long-stay travellers, and those visiting areas of poor sanitation.

Hepatitis A
Vaccination recommended for all previously unvaccinated travellers. Hepatitis A vaccine is well tolerated and affords long-lasting protection.

Hepatitis B
Vaccination recommended for travellers whose activities or medical history put them at increased risk, including those who may have unprotected sex, those who may be exposed to contaminated needles (eg, through injecting drug use or receiving medical or dental care), those who may be exposed to blood or body fluids through their work (eg, health workers), long-stay travellers, those who are participating in contact sports and families adopting children from this country.

Meningitis ACWY
Vaccination recommended for travellers whose activities or medical condition put them at increased risk, including healthcare workers, travellers visiting friends and relatives, those who live or travel ‘rough’ such as backpackers, long-stay travellers who have close contact with the local population, those with complement disorders and those who do not have a functioning spleen.

Consider immunisation depending on type of activity (eg, running, cycling), occupation (eg, veterinary surgeons) and length of stay. Travellers should be aware of first aid measures and the need to seek prompt medical attention in the event of possible rabies exposure.

Consider immunisation in certain circumstances. Travellers at higher risk include humanitarian aid workers and travellers with remote itineraries in areas of cholera outbreaks, who have limited access to safe water and medical care.

Yellow fever
Vaccination is recommended for travellers aged 9 months and older going to areas south of the Sahara.

Vaccination is not recommended for those whose travel is limited to areas in the Sahara.

International Certificate of Vaccination or Prophylaxis (ICVP) required if arriving from a country with a risk of yellow fever transmission.

- applies to travellers from 12 months of age.

If a receiving country requires an ICVP as a condition of entry, and the individual should not receive the vaccine on medical grounds, a letter of medical exemption can be considered.

Travellers should have completed a primary vaccination course according to the UK schedule. If travelling to a country where medical facilities may be limited, a booster dose of a tetanus-containing vaccine is recommended if the last dose was more than ten years ago even if five doses of vaccine have been given previously.

Vaccination recommended for travellers at increased risk of developing severe disease and/or of exposure to TB, including unvaccinated children under 16 years of age who are going to live for more than 3 months in this country and unvaccinated, tuberculin skin test negative individuals under 35 years of age at risk because of their work (eg, healthcare workers, prison staff and vets).

Further information

Abbreviated information provided by the National Travel Health Network and Centre (NaTHNaC). Refer to the Mauritania page on for full details.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases